233 related articles for article (PubMed ID: 16088988)
1. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin.
Jeon O; Ryu SH; Chung JH; Kim BS
J Control Release; 2005 Jul; 105(3):249-59. PubMed ID: 16088988
[TBL] [Abstract][Full Text] [Related]
2. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
[TBL] [Abstract][Full Text] [Related]
3. Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis.
Yang HS; Bhang SH; Hwang JW; Kim DI; Kim BS
Tissue Eng Part A; 2010 Jun; 16(6):2113-9. PubMed ID: 20136400
[TBL] [Abstract][Full Text] [Related]
4. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of sustained delivery of basic fibroblast growth factor and bone marrow mononuclear cell transplantation on angiogenesis in mouse ischemic limbs.
Jeon O; Kang SW; Lim HW; Choi D; Kim DI; Lee SH; Chung JH; Kim BS
Biomaterials; 2006 Mar; 27(8):1617-25. PubMed ID: 16174524
[TBL] [Abstract][Full Text] [Related]
6. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
7. Development of fibrin derivatives for controlled release of heparin-binding growth factors.
Sakiyama-Elbert SE; Hubbell JA
J Control Release; 2000 Apr; 65(3):389-402. PubMed ID: 10699297
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of nerve growth factor from fibrin gel.
Bhang SH; Jeon O; Choi CY; Kwon YH; Kim BS
J Biomed Mater Res A; 2007 Mar; 80(4):998-1002. PubMed ID: 17117469
[TBL] [Abstract][Full Text] [Related]
9. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
Ho YC; Mi FL; Sung HW; Kuo PL
Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.
Matonick JP; Hammond J
J Invest Surg; 2014 Dec; 27(6):360-5. PubMed ID: 25361019
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation.
Marui A; Kanematsu A; Yamahara K; Doi K; Kushibiki T; Yamamoto M; Itoh H; Ikeda T; Tabata Y; Komeda M
J Vasc Surg; 2005 Jan; 41(1):82-90. PubMed ID: 15696049
[TBL] [Abstract][Full Text] [Related]
12. Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo.
Wang H; Zou Q; Boerman OC; Nijhuis AW; Jansen JA; Li Y; Leeuwenburgh SC
J Control Release; 2013 Mar; 166(2):172-81. PubMed ID: 23266450
[TBL] [Abstract][Full Text] [Related]
13. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
[TBL] [Abstract][Full Text] [Related]
14. Controlled delivery of basic fibroblast growth factor (bFGF) using acoustic droplet vaporization stimulates endothelial network formation.
Dong X; Lu X; Kingston K; Brewer E; Juliar BA; Kripfgans OD; Fowlkes JB; Franceschi RT; Putnam AJ; Liu Z; Fabiilli ML
Acta Biomater; 2019 Oct; 97():409-419. PubMed ID: 31404713
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with sustained-release basic fibroblast growth factor and heparin enhances neovascularization in hypercholesterolemic mouse hindlimb ischemia.
Arai Y; Fujita M; Marui A; Hirose K; Sakaguchi H; Ikeda T; Tabata Y; Komeda M
Circ J; 2007 Mar; 71(3):412-7. PubMed ID: 17322644
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model.
Horikoshi-Ishihara H; Tobita M; Tajima S; Tanaka R; Oshita T; Tabata Y; Mizuno H
J Vasc Surg; 2016 Dec; 64(6):1825-1834.e1. PubMed ID: 26597457
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of bioactive transforming growth factor beta-1 from fibrin gels in vitro.
Catelas I; Dwyer JF; Helgerson S
Tissue Eng Part C Methods; 2008 Jun; 14(2):119-28. PubMed ID: 18544028
[TBL] [Abstract][Full Text] [Related]
18. Release kinetics of basic fibroblast growth factor (bFGF) from certain biopolymers in the presence of ketoprofen.
Michalska M; Mirowski M; Bodek A; Bodek KH
Pharmazie; 2010 Nov; 65(11):818-23. PubMed ID: 21155388
[TBL] [Abstract][Full Text] [Related]
19. Binding of basic fibroblast growth factor to fibrinogen and fibrin.
Sahni A; Odrljin T; Francis CW
J Biol Chem; 1998 Mar; 273(13):7554-9. PubMed ID: 9516457
[TBL] [Abstract][Full Text] [Related]
20. Growth factor- and heparin-dependent regulation of constitutive and agonist-mediated human endothelial barrier function.
Moy AB; Blackwell K; Wu MH; Granger HJ
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2126-35. PubMed ID: 16679398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
